Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders
Author:
Publisher
Frontiers Media SA
Subject
General Medicine
Reference80 articles.
1. Autoimmune paraneoplastic syndromes associated to lung cancer: a systematic review of the literature;Durieux;Lung Cancer.,2017
2. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4;Tivol;Immunity.,1995
3. The PD1:PD-L1/2 pathway from discovery to clinical implementation;Bardhan;Front Immunol.,2016
4. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations;Schubert;Nat Med.,2014
5. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4;Kuehn;Science.,2014
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease;European Journal of Cancer;2024-08
2. Potential applications of JAK inhibitors, clinically approved drugs against autoimmune diseases, in cancer therapy;Frontiers in Pharmacology;2024-01-03
3. Biological characteristics and clinical management of uveal and conjunctival melanoma;Oncology Research;2024
4. Weighing Risks and Benefits in the Presence of Competing Risks;Current Epidemiology Reports;2023-09-22
5. Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology;Journal for ImmunoTherapy of Cancer;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3